318 related articles for article (PubMed ID: 26627723)
1. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
2. A novel role of IL-17A in contributing to the impaired suppressive function of Tregs in psoriasis.
Liu Y; Zhang C; Li B; Yu C; Bai X; Xiao C; Wang L; Dang E; Yang L; Wang G
J Dermatol Sci; 2021 Feb; 101(2):84-92. PubMed ID: 33334656
[TBL] [Abstract][Full Text] [Related]
3. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
4. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
[TBL] [Abstract][Full Text] [Related]
5. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis.
Yan K; Han L; Deng H; Fang X; Zhang Z; Huang G; Zheng ZZ; Huang Q; Xu J
J Dermatol Sci; 2018 Oct; 92(1):106-113. PubMed ID: 30072243
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of regulatory molecules in the skin of psoriasis.
Sabag AD; Dias-Polak D; Bejar J; Sheffer H; Bergman R; Vadasz Z
Immunol Res; 2018 Dec; 66(6):649-654. PubMed ID: 30613859
[TBL] [Abstract][Full Text] [Related]
7. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
Benito-Miguel M; García-Carmona Y; Balsa A; Pérez de Ayala C; Cobo-Ibáñez T; Martín-Mola E; Miranda-Carús ME
J Immunol; 2009 Dec; 183(12):8268-79. PubMed ID: 20007590
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Akt-FOXO1 Pathway Leads to Dysfunction of Regulatory T Cells in Patients with Psoriasis.
Li B; Lei J; Yang L; Gao C; Dang E; Cao T; Xue K; Zhuang Y; Shao S; Zhi D; Hao J; Jin L; Qiao P; Ouyang W; Wang G
J Invest Dermatol; 2019 Oct; 139(10):2098-2107. PubMed ID: 30998985
[TBL] [Abstract][Full Text] [Related]
9. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
10. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder.
Zhang K; Li X; Yin G; Liu Y; Niu X; Hou R
Br J Dermatol; 2008 Feb; 158(2):298-305. PubMed ID: 18070209
[TBL] [Abstract][Full Text] [Related]
12. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.
Sestito R; Madonna S; Scarponi C; Cianfarani F; Failla CM; Cavani A; Girolomoni G; Albanesi C
FASEB J; 2011 Mar; 25(3):916-27. PubMed ID: 21098725
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73/AMPK/mTOR pathway.
Yan K; Xu W; Huang Y; Zhang Z; Huang Q; Xin KZ; Ma Y; Han L
Br J Dermatol; 2018 Oct; 179(4):896-905. PubMed ID: 29572822
[TBL] [Abstract][Full Text] [Related]
14. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
[TBL] [Abstract][Full Text] [Related]
15. Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.
Kanda N; Kamata M; Tada Y; Ishikawa T; Sato S; Watanabe S
J Leukoc Biol; 2011 Jun; 89(6):935-44. PubMed ID: 21367976
[TBL] [Abstract][Full Text] [Related]
16. STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cells.
Schmetterer KG; Neunkirchner A; Wojta-Stremayr D; Leitner J; Steinberger P; Pickl WF
FASEB J; 2015 Mar; 29(3):759-71. PubMed ID: 25398767
[TBL] [Abstract][Full Text] [Related]
17. A possible pathogenic role of CD4+CD25+ T-regulatory cells in psoriasis.
Shehata IH; Elghandour TM
Egypt J Immunol; 2007; 14(1):21-31. PubMed ID: 18689278
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1/STAT3 in psoriasis.
Yan K; Zhang F; Ren J; Huang Q; Yawalkar N; Han L
J Transl Med; 2023 Sep; 21(1):678. PubMed ID: 37773129
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function.
Herrath J; Müller M; Amoudruz P; Janson P; Michaëlsson J; Larsson PT; Trollmo C; Raghavan S; Malmström V
Eur J Immunol; 2011 Aug; 41(8):2279-90. PubMed ID: 21607944
[TBL] [Abstract][Full Text] [Related]
20. Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model.
Nadeem A; Al-Harbi NO; Ansari MA; Al-Harbi MM; El-Sherbeeny AM; Zoheir KMA; Attia SM; Hafez MM; Al-Shabanah OA; Ahmad SF
Biochem Pharmacol; 2017 Jan; 124():69-82. PubMed ID: 27984001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
